Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Overview
Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Companies Involved in Therapeutics Development
Daiichi Sankyo Co Ltd
Galmed Pharmaceuticals Ltd
Japan Tobacco Inc
Lipidio Pharmaceuticals Inc
Modulation Therapeutics Inc
Sumitomo Dainippon Pharma Co Ltd
Takeda Pharmaceutical Co Ltd
Yumanity Therapeutics
Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Drug Profiles
Aramchol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Aramchol Meglumine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DSP-0692 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Dormant Products
Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Discontinued Products
Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Product Development Milestones
Featured News & Press Releases
Appendix



List of Figures


Number of Products under Development by Stage of Development, H2 2020
Number of Products under Development by Therapy Areas, H2 2020
Number of Products under Development by Top 10 Indications, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020


List of Tables


Number of Products under Development by Stage of Development, H2 2020
Number of Products under Development by Therapy Areas, H2 2020
Number of Products under Development by Indication, H2 2020
Number of Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Pipeline by Daiichi Sankyo Co Ltd, H2 2020
Pipeline by Galmed Pharmaceuticals Ltd, H2 2020
Pipeline by Japan Tobacco Inc, H2 2020
Pipeline by Lipidio Pharmaceuticals Inc, H2 2020
Pipeline by Modulation Therapeutics Inc, H2 2020
Pipeline by Sumitomo Dainippon Pharma Co Ltd, H2 2020
Pipeline by Takeda Pharmaceutical Co Ltd, H2 2020
Pipeline by Yumanity Therapeutics, H2 2020
Dormant Projects, H2 2020
Discontinued Products, H2 2020